TRPM7 and pancreatic adenocarcinoma: Therefore, immense potential exists for TRPM7 and TRPM8 channels to be developed as clinically useful biomarkers and valid therapeutic targets with the hope of accomplishing personalized therapy for patients with pancreatic adenocarcinoma and other malignant diseases [48].